PharmaCyte Biotech, Inc. (PMCB)

NCM – Real Time Price. Currency in USD

0.79

+0.10 (13.69%)

At close: May 12, 2026, 4:00 PM EDT

0.77

-0.02 (-2.00%)

Pre-market: May 13, 2026, 7:22 AM EDT

25.11.2025

PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment

LAS VEGAS--(BUSINESS WIRE)--PharmaCyte Biotech, Inc. (Nasdaq:PMCB) (“PharmaCyte” or the “Company”), today announced the successful monetization of its stake in Femasys Inc. (NASDAQ: FEMY), further validating the Company's strategic approach to capital deployment and strengthening its already solid financial position. Following the monetization of the stake, PharmaCyte's cash and marketable securities are expected to increase to approximately $20 million, up from $13.3 million as of July 31, 202.

Videos

No Data

There is no data to display

Press releases

25.11.2025

PharmaCyte Biotech, Inc. (PMCB)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

PharmaCyte Biotech, Inc. (PMCB)

PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment

Videos

No Data

Press releases

PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment

PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment

Videos

No Data

Press releases

PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment

Search stocks

PharmaCyte Biotech, Inc. (PMCB)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

PharmaCyte Biotech, Inc. (PMCB)

PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment

Videos

No Data

Press releases

PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment

PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment

Videos

No Data

Press releases

PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment